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Summary of human Vibrio cases reported to CDC, 2007 
The Cholera and Other Vibrio Illness Surveillance (COVIS) system is a national database of reported 
human illnesses caused by all species of Vibrio; the COVIS database is maintained by CDC. This 
information has been used to educate consumers about the health risks of seafood, as well as to help 
determine host, food, and environmental risk factors. 
COVIS was initiated by CDC, the Food and Drug Administration (FDA), and the Gulf Coast states 
(Alabama, Florida, Louisiana, Mississippi, and Texas) in 1988.  Using the Cholera and Other Vibrio 
Illness Surveillance Report (available at 
http://www.cdc.gov/nationalsurveillance/PDFs/CDC5279_COVISvibriosis.pdf), participating health 
officials collect clinical data, information about underlying illness, history of seafood consumption and 
exposure to seawater in the 7 days before illness.  Participants also conduct tracebacks of implicated 
seafood. Surveillance has expanded nationally, with most states reporting cases since 1997.  
Historically, only toxigenic V. cholerae serogroups O1 and O139 were nationally notifiable; therefore, 
the numbers of non-toxigenic Vibrio isolates were likely underreported.  However, in January 2007, 
infections caused by any Vibrio species (vibriosis) became nationally notifiable, although many cases of 
vibriosis are undetected by clinical laboratories because vibrios are not easily identified on routine 
enteric media.  Additionally, CDC serotypes all V. parahaemolyticus isolates received from state health 
departments, tests for serogroups O1, O75, O139, and O141, and determines cholera toxin production 
for all V. cholera isolates. 
This report summarizes human Vibrio infections during 2007 reported by states to CDC. Results are 
presented in two categories: V. cholerae isolates that produce cholera toxin (referred to as toxigenic 
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Vibrio cholerae), and all other Vibrio isolates, including those V. cholerae isolates that do not produce 
cholera toxin. This report differs from previous reports, in that results for the entire country are 
presented together rather than including a separate section for Gulf Coast states.  Additionally, results 
are presented by specimen type. It is important to note that isolation of some Vibrio species from a 
patient with illness does not necessarily indicate causation.  While many Vibrio species are well-
recognized pathogens, the status of V. damsela, V. furnissii, V.metschnikovii, and V. cincinnatiensis as 
enteric or wound pathogens is less clear. 
Toxigenic Vibrio cholerae 
In 2007, seven patients with toxigenic V. cholerae serogroup O1 (cholera), one patient with toxigenic V. 
cholerae serogroup O141, and one patient with toxigenic V. cholerae serogroup O75 were reported 
(Table 1). Of the seven toxigenic V. cholerae serogroup O1 cases, five patients were hospitalized and no 
deaths were reported. Infection was acquired through international travel in four cases (two patients 
acquired infection while traveling in India, one while traveling in Bangladesh, and one while traveling in 
Pakistan). Of the two patients who acquired infection in India, one was a vegetarian who reported no 
recreational water exposure and the other reported no seafood consumption but reported recreational 
water exposure. The patient who traveled to Bangladesh reported consuming fish while abroad.  The 
patient who traveled to Pakistan reported no seafood or recreational water exposure.  All patients with 
domestically-acquired infection reported having eaten seafood.  Two of the patients reported eating raw 
oysters that traced back to the Louisiana Gulf Coast.  The third patient reported eating fried shrimp and 
catfish; no traceback was undertaken. 
No travel or seafood consumption was reported by the patient with toxigenic V. cholerae serogroup 
O141 infection. He did consume queso fresco that was brought from Mexicali, Mexico.  Four members 
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of the patient’s family who also consumed the queso fresco reported diarrhea and cramping that began 
on October 15 and 16, but cultures were not performed on the family members.  The source of the 
cheese in Mexico is unknown. No hospitalization was required. 
The patient infected with V. cholerae serogroup O75 had traveled domestically to Florida where he ate 
at an oyster bar. Health officials were unable to reach the patient to get a more detailed food history, 
and no traceback was undertaken. No hospitalization was required. 
Table 1: Cases of toxigenic V. cholerae, 2007 
State Age Sex Onset Exposure Serogroup Serotype 
Arizona 39 M 9/20/2007 Domestic-seafood (Gulf Coast) V. cholerae O1 Inaba 
California 55 F 9/2/2007 Travel in India V. cholerae O1 Ogawa 
Kentucky 46 M 9/28/2007 Domestic-seafood (Gulf Coast) V. cholerae O1 Inaba 
Travel in India, Thailand, and 
Michigan 24 F 6/27/2007 Cambodia V. cholerae O1 Ogawa 
New York 23 M 8/28/2007 Travel in Bangladesh V. cholerae O1 Ogawa 
Ohio 10 F 8/28/2007 Travel in Pakistan V. cholerae O1 Ogawa 
Texas 65 F 8/9/2007 
Domestic-seafood(harvest area 
unknown) V. cholerae O1 Inaba 
California 15 M 10/12/2007 
Domestic- imported queso 
fresco suspected V. cholerae O141 
Alabama 43 M 10/20/2007 
Domestic-seafood(harvest area 
unknown) V. cholerae O75 
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Other Vibrio Illnesses (excluding toxigenic V. cholerae) 
In 2007, Vibrio isolates from 549 patients were reported to COVIS (Table 2). Among patients for whom 
information was available, 199 (39%) of 512 were hospitalized and 36 (7%) of 488 died. V. 
parahaemolyticus was isolated from 232 (42%) of the 549 patients, and this was the most frequently 
reported Vibrio species. Of the patients infected with V. parahaemolyticus, 52 (24%) of 221 with 
information were hospitalized and none died.  V. vulnificus was isolated from 95 (17%) of the 549 
patients; 87 (93%) of 94 with information were hospitalized and 30 (36%) of 83 with information died. 
Table 2. Number of Vibrio illnesses (excluding toxigenic V. cholerae) by species, complications, and site 
of isolation in patients from the United States, 2007. 






























































































































































Total 549 100 199/512 39 36/488 7 573 100 236 101 160 76
1 Denominators indicate patients for whom information is known. 

2 Isolation of the same Vibrio species can occur from more than one specimen per patient; therefore, the number of isolates 

can be higher than the total number of patients. 

3Includes ear, urine, bile, and other. 

4Includes non-toxigenic V. cholerae O1 (5 isolates) and other non-toxigenic V. cholerae [non-O1 non-O139] 

  (46 isolates). 
5The following were isolated from one patient: V. alginolyticus and V. parahaemolyticus; V. cholerae (non-toxigenic) and V. 
hollisae; V. damsela and V. parahaemolyticus; V. fluvialis and V. mimicus; V. fluvialis and V. parahaemolyticus; V. 
alginolyticus and an unidentified Vibrio species; V. parahaemolyticus and an unidentified Vibrio species; V. vulnificus and an 





Of the 549 cases in 2007, CDC received 159 (29%) reports of Vibrio illness from Gulf Coast states, 
146 (27%) from Pacific Coast states, 187 (34%) from Atlantic Coast states (excluding Florida, which 
is included with Gulf Coast states), and 57 (10%) from inland states (Figure 1). The most frequent 
Vibrio species reported from Gulf Coast states were V. vulnificus (34%), V. parahaemolyticus (27%), 
V. alginolyticus (15%), and non-toxigenic V. cholerae (9%). The most frequent Vibrio species 
reported from non-Gulf Coast states were V. parahaemolyticus (48%), V. alginolyticus (19%), V. 
vulnificus (11%), and non-toxigenic V. cholerae (8%). 
Figure 1. Number of cases of Vibrio illnesses (excluding toxigenic V. cholerae), by state, 2007 




























































Among the 573 Vibrio isolates (excluding toxigenic V. cholera) in 2007, 236 (41%) were from stool, 
101 (18%) from blood, and 160 (28%) from wounds.  Fifty-six (10%) isolates were obtained from the 
ear, of which 30 (54%) were V. alginolyticus. An additional 20 isolates (3%) were from urine, bile, or 
other site. V. parahaemolyticus was the species most frequently isolated from stool (164 [69%] of 236 
isolates from stool); V. vulnificus was the species most frequently isolated from blood (69 [68%] of 101 
isolates from blood); and V. alginolyticus was the species most frequently isolated from wounds (56 
[35%] of 160 isolates from wounds). 
Seasonality 
Cases of Vibrio infection had a clear seasonal peak during the summer months (Figure 2).  Most cases 
(70%) occurred during May-September, with the greatest frequency during August. 
Figure 2. Number of cases of Vibrio illnesses (excluding toxigenic V. cholerae), by month of illness 
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Exposures 
One-hundred-thirty (24%) of 549 patients reported having a wound either before or during exposure to 
Vibrio. Of those 130 patients, 121 (93%) reported having skin exposed to a body of water, 38 (29%) 
reported contact with marine wildlife, and 33 (25%) reported handling seafood. Excluding patients with 
wound infections, among the 276 for whom a food history was available, 245 (89%) reported eating 
seafood in the 7 days before illness onset. Among the 119 who reported eating a single seafood item 
(Table 4), 58% ate oysters (97% of whom consumed them raw), 13% ate finfish, and 11% ate clams 
(83% of whom consumed them raw).  International travel in the seven days before illness onset was 
reported by 38 (7.9%) of 476 patients for whom travel information was available. 
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Table 4. Seafood exposure among patients with foodborne Vibrio infection (excluding toxigenic V. cholerae) who reported eating a single seafood 
item in the week before illness onset, 2007  
Mollusks Crustaceans 
Oysters Clams Mussels Shrimp Lobster Crab Crayfish Other Shellfish1 Finfish2 Total 
Patients who 
ate the single 
item (%) 
69 (58) 13 (11) 1 (1) 11 (9) 0 9 (8) 0 1 (1) 15 (13) 119 
Subset that 
ate the item 
raw, % 
97 83 0 11 -- 0 -- 0 40 --
1 Other shellfish reported: scallop.
 





CDC received 76 isolates of V. parahaemolyticus, of which 69 were serotyped. Of these, 10 (14%) were 
serotype O4:K12, 10 (14%) isolates were O4:Kuk, 9 (13%) isolates were O1:Kuk, 7 (10%) were 
O5:Kuk, 4 (6%) were O10:Kuk, 3 (4%) isolates were of the pandemic clone serotype O3:K6, and the 
remaining 26 isolates (38%) were 18 different serotypes.    
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